Matches in Wikidata for { <http://www.wikidata.org/entity/Q93207439> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q93207439 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q93207439 description "scientific article published on 01 April 2020" @default.
- Q93207439 description "wetenschappelijk artikel" @default.
- Q93207439 description "наукова стаття, опублікована 1 квітня 2020" @default.
- Q93207439 name "A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia" @default.
- Q93207439 name "A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia" @default.
- Q93207439 type Item @default.
- Q93207439 label "A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia" @default.
- Q93207439 label "A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia" @default.
- Q93207439 prefLabel "A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia" @default.
- Q93207439 prefLabel "A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia" @default.
- Q93207439 P1476 Q93207439-6A573215-2CF3-4183-9B41-F32AC38674A3 @default.
- Q93207439 P2093 Q93207439-0364F7D5-7F1F-49D0-B666-5D9078C3487F @default.
- Q93207439 P2093 Q93207439-08AE1E30-13C6-4DA9-A66C-09BFD21535F5 @default.
- Q93207439 P2093 Q93207439-08C95E99-639E-4610-9781-8FE2BD23AD75 @default.
- Q93207439 P2093 Q93207439-0996CCA9-F2B7-4771-95A8-3DA0B54DE987 @default.
- Q93207439 P2093 Q93207439-1595CD3D-63D9-4353-A9A8-F8C657A432BE @default.
- Q93207439 P2093 Q93207439-1AAB7108-A42C-411E-BF00-75F786229564 @default.
- Q93207439 P2093 Q93207439-34AF5AEA-878D-436B-9661-669C2D5026C7 @default.
- Q93207439 P2093 Q93207439-4C33B851-BCD7-4BF4-9B94-F37C1FC89D2E @default.
- Q93207439 P2093 Q93207439-530FF8B7-E8FF-4B6A-AB4D-36990840693A @default.
- Q93207439 P2093 Q93207439-5CBDC737-493A-4270-ACB4-4A5CCB02912D @default.
- Q93207439 P2093 Q93207439-67646103-5BA3-4D6F-A372-4D8E3A0A16BB @default.
- Q93207439 P2093 Q93207439-6BBD0436-5BA9-402B-8F77-1090844ADF6E @default.
- Q93207439 P2093 Q93207439-7C7B9CBE-C8E7-4415-A91E-23AC5C0F489D @default.
- Q93207439 P2093 Q93207439-B26613DF-14FF-48C3-A2A6-D2FE8BDA6AA8 @default.
- Q93207439 P2093 Q93207439-D8AC64B9-9E11-4C8F-BC50-3E0B58AA20F5 @default.
- Q93207439 P2093 Q93207439-F8D3D775-BC3F-46CE-B088-9E2DC8792A4E @default.
- Q93207439 P304 Q93207439-2A1AE907-C932-4A7F-B388-A6C34F6D85BA @default.
- Q93207439 P31 Q93207439-0C602424-4AF4-4D1B-A40F-E1DD201C6DB7 @default.
- Q93207439 P356 Q93207439-AAF8A1F5-D3E9-4553-89A4-E2A5FDB26ED8 @default.
- Q93207439 P433 Q93207439-342ED701-BC8B-4E34-96FC-9028A9BE1E86 @default.
- Q93207439 P478 Q93207439-D41D0F69-35BA-4389-A5C5-8D17CCA559C6 @default.
- Q93207439 P577 Q93207439-43E3B540-8785-45D7-9AD5-14E96D2DA05D @default.
- Q93207439 P698 Q93207439-FCA6798A-A4B6-4B7F-8063-49CACAFA58CA @default.
- Q93207439 P921 Q93207439-4D2FBF0D-A26D-42B4-BE69-0AB3694C262D @default.
- Q93207439 P932 Q93207439-49E8320B-E42F-46BD-8325-B4A87AAB03B9 @default.
- Q93207439 P356 BLOODADVANCES.2020001449 @default.
- Q93207439 P698 32330242 @default.
- Q93207439 P1476 "A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia" @default.
- Q93207439 P2093 "Alexander E Perl" @default.
- Q93207439 P2093 "Bao Lam" @default.
- Q93207439 P2093 "Brian L West" @default.
- Q93207439 P2093 "Catherine C Smith" @default.
- Q93207439 P2093 "Chao Zhang" @default.
- Q93207439 P2093 "Eunice S Wang" @default.
- Q93207439 P2093 "Gail J Roboz" @default.
- Q93207439 P2093 "Gideon Bollag" @default.
- Q93207439 P2093 "Henry H Hsu" @default.
- Q93207439 P2093 "John M Pagel" @default.
- Q93207439 P2093 "Mai H Le" @default.
- Q93207439 P2093 "Mark J Levis" @default.
- Q93207439 P2093 "Olga Frankfurt" @default.
- Q93207439 P2093 "Paul L Severson" @default.
- Q93207439 P2093 "Richard M Stone" @default.
- Q93207439 P2093 "Sabine Kayser" @default.
- Q93207439 P304 "1711-1721" @default.
- Q93207439 P31 Q13442814 @default.
- Q93207439 P356 "10.1182/BLOODADVANCES.2020001449" @default.
- Q93207439 P433 "8" @default.
- Q93207439 P478 "4" @default.
- Q93207439 P577 "2020-04-01T00:00:00Z" @default.
- Q93207439 P698 "32330242" @default.
- Q93207439 P921 Q264118 @default.
- Q93207439 P932 "7189289" @default.